Privi Speciality Chemicals (NSE:PRIVISCL, BOM:530117) has received a Certificate of Active Pharmaceuticals Ingredient Product Listing and a Certificate of Registration for its Camphor product from the US Food and Drug Administration.
The company already has a license to manufacture and sell Camphor in India from the Food and Drugs Administration, Maharashtra State, which allows it to sell the product to Indian pharmaceutical companies.
With this latest certification, the company can expand in the area of pharmaceutical applications in the US.
Price (INR): â¹1587.90, Change: â¹+33, Percent Change: +2.14%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments